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INTRODUCTION 56
The rapid evolution of RNA viruses represents a significant challenge for preventing, treating, 57 and eradicating RNA viral diseases. High mutation rates in RNA viruses generate extensive 58 opportunities to overcome evolutionary hurdles, such as antiviral drugs, host immunity, or 59 engineered attenuating changes (1). The evolutionary pathways traversed by RNA viruses are 60 shaped by natural selection, which will favor some evolutionary trajectories more than others 61 based on whether mutations are beneficial, deleterious, or neutral (2). Predicting the likely results 62 of RNA virus evolution is an important step for anticipating viral emergence and for developing 63 escape-resistant antiviral drugs and vaccines (3, 4). 64 65 Coronaviruses (CoVs) are a family of positive-sense RNA viruses that cause human illnesses 66 ranging from the common cold to severe and lethal respiratory disease (5). All CoVs encode a 67 proofreading exoribonuclease within nonstructural protein 14 (nsp14-ExoN) that is critical for 68 replication, fidelity, fitness, and virulence, and ExoN-inactivation has been proposed as a 69 strategy for live-attenuated vaccine development (6-15). As members of the DEDDh superfamily 70 of exonucleases, CoV ExoNs hydrolyze nucleotides using four metal-coordinating amino acids 71
arranged in 3 motifs: I (DE), II (E), III (D) (16, 17). Alanine substitution of ExoN motif I (DE-72
to-AA) disrupts ExoN biochemical activity in both SARS-CoV and human CoV 229E (hCoV-73 229E) (16, 18, 19) . The betacoronaviruses murine hepatitis virus (MHV) and SARS-CoV 74 tolerate disruption of ExoN activity [ExoN(-)] but display mutator phenotypes accompanied by 75 defects in replication, competitive fitness, and evasion of innate immune responses (10, 13, 14) . 76
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The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/618249 doi: bioRxiv preprint ExoN active site mutants in alphacoronaviruses, including transmissible gastroenteritis virus and 77 hCoV-229E, have yet to be recovered and are proposed to be lethal for replication (19, 20) . 78
79
Given the critical role of ExoN in CoV biology and the elevated mutation rate, we expected that 80 natural selection would repeatedly drive reversion of the ExoN-inactivating substitutions. In line 81 with this expectation, ExoN motif III mutants of SARS-CoV and MHV rapidly and repeatedly 82 revert ((14) and unpublished observations). In contrast, we have never detected partial or 83 complete reversion of ExoN motif I mutants (ExoN-AA) in SARS-CoV or MHV during 10 years 84 of study and hundreds of experiments. More specifically, we have not detected consensus or 85 minority variants of any kind at the motif I AA codons in either virus strain during acute 86 infections and prolonged passage in tissue culture and following treatment with multiple 87 nucleoside analogues (6-11, 13, 14) . SARS-CoV-ExoN-AA also is stable during acute and 88 persistent animal infections in immunocompetent and immune-compromised mice (12) . The lack 89 of primary reversion is not due simply to reduced adaptive capacity, as both SARS-CoV-and 90 MHV-ExoN-AA can adapt for increased replication (7, 14) . Most strikingly, long-term passage 91 of MHV-ExoN-AA (250 passages, P250) yielded a highly fit population that had directly 92 compensated for defective proofreading through evolution of a likely high-fidelity RdRp (7 The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/618249 doi: bioRxiv preprint
RESULTS

110
Primary reversion of ExoN(-) motif I. MHV-ExoN(-), hereafter ExoN-AA, contains two 111 engineered substitutions in each codon of motif I, such that complete reversion to WT-ExoN-DE 112 requires mutations to all four sites ( Figure 1A ). Viral mutation rates in the absence of 113 proofreading range from 10 -4 to 10 -6 mutations per nucleotide per round of replication (µ) (1). 114
Assuming an ExoN-AA mutation rate of 10 -4 µ and accounting for codon degeneracy, the 115 probability of restoring the native amino acid sequence in a single round of replication is 10 -18 . 116
Only rarely do ExoN-AA titers exceed 10 6 PFU/mL, so it is unlikely that ExoN-AA could 117 navigate this genetic barrier in a single infectious cycle. Thus, we hypothesized that ExoN-AA 118 reversion, if possible, would proceed incrementally. To identify potential pathways towards 119
ExoN-AA reversion, we examined the possible single-nucleotide substitutions surrounding A89 120 and A91 ( Figure 1B ). Three mutations are synonymous, and five mutations yield amino acids 121 unlikely to coordinate with the positively-charged metals required for ExoN catalysis (glycine, 122 valine, proline, threonine, and serine) (16, 19, 21, 22) . One mutation per site can restore the 123 acidic charge (i.e. AA-to-ED) but not the native amino acid. These variants have not been tested 124 in a CoV ExoN, but biochemical studies of E. coli DNA polymerase I ExoN mutants suggest that 125 these conservative substitutions would not restore WT-like ExoN activity (23) . We predicted 126 stepwise pathways to ExoN-AAàDE reversion based on restoration of acidic charge followed 127 by reversion to native amino acids ( Figure 1C 
D89 E91
GAT GAA
A89 A91
GCA GCT
WT-ExoN-DE
ExoN-AA
A B
ExoN Motif I C All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. 
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/618249 doi: bioRxiv preprint Adaptive mutations in nsp12 and nsp14 that increase ExoN-AA fitness confer significant 208 fitness costs to WT-ExoN-DE. Mutational fitness effects are highly dependent upon the genetic 209 background (25-27). In addition to reducing selective pressure for reversion, mutations 210 conferring increased fitness to ExoN-AA might also reduce the benefits of motif I reversion. We 211 previously reported that long-term passage of ExoN-AA selects for secondary adaptive 212 mutations in the nsp12 RdRp and nsp14 (nsp12-P250 and nsp14-P250) (7). Nsp12-P250 contains 213 7 nonsynonymous mutations that partially compensate for defective proofreading and increase 214
ExoN-AA fitness. Nsp14-P250 contains 6 nonsynonymous mutations, including a conservative 215 D-to-E substitution in ExoN motif III, and increases ExoN-AA fitness without compensating for 216 defective proofreading. To test whether the fitness effects of passage-associated mutations in 217 nsp12-P250 and nsp14-P250 depend upon the ExoN-AA genotype, we engineered a WT motif I 218 (ExoN-DE) into viruses containing nsp12-P250 and nsp14-P250, alone and together, and 219 analyzed replication, 5-FU sensitivity, and competitive fitness. Compared to WT-ExoN-DE, both 220
ExoN-DE-nsp12-P250 and ExoN-DE-nsp14-P250 displayed delayed and decreased replication 221 ( Figure 4A ). In 5-FU sensitivity assays, ExoN-DE-nsp14-P250 was indistinguishable from WT-222
ExoN-DE, while both variants containing nsp12-P250 (ExoN-DE-nsp12-P250 and ExoN-DE-223
nsp12/14-P250) were significantly more sensitive to 5-FU ( Figure 4B) . Finally, the nsp12-P250 224 and nsp14-P250 mutations significantly decreased fitness relative to WT-ExoN-DE ( Figure 4C) . 225 We detected no statistical differences between the specific infectivity of WT-ExoN-DE and any 226 of the nsp12-P250 and nsp14-P250 variants in isolated infections ( Figure 4D ). Thus, mutations 227 in nsp12 and nsp14 that arose in the ExoN-AA background were detrimental to replication, 228 mutagen sensitivity, and competitive fitness in the presence of a fully-reverted ExoN-DE. These 229
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. However, secondary mutations that incrementally increase fitness are more accessible (solid white arrow). Eventually, the genetic background changes enough that reversion becomes detrimental (dotted yellow line). profound replication or fitness defects, selection could drive primary reversion more quickly 259 away from this genotype. Consistent with this hypothesis, ExoN-AE reverted more quickly at a 260 higher MOI, where natural selection acts more efficiently on a larger population size (Table 1) they must coevolve in a highly cooperative manner to maintain their essential functions. 268
Consistent with this hypothesis, the fitness effects of mutations in nsp12-P250 and nsp14-P250 269 differ based on the motif I genotype; they are beneficial in ExoN-AA but detrimental in the WT-270
ExoN-DE background. In previous studies, it has been difficult to determine whether the fitness 271 defects in ExoN(-) CoVs are directly linked to low-fidelity replication or through some other 272 mechanism. Our data suggest that the proofreading function of nsp14-ExoN can be uncoupled 273 from its more general role in replication (Figure 4) , providing an opportunity to examine 274 additional roles for this essential protein. Nsp12-P250 also will be an important tool for 275 understanding the relationship between RdRp fidelity and ExoN proofreading during CoV 276 replication and for studying replication complex assembly and interactions. Our studies suggest 277 that compensatory mutations identified through long-term passage could stabilize the ExoN-AA 278 genotype. In particular, the high-fidelity nsp12-P250 could reduce the probability of reversion by 279 reducing mutational sampling within motif I (30), and both nsp12-P250 and nsp14-P250 render The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/618249 doi: bioRxiv preprint Cloning and recovery of recombinant viruses. Site-directed mutagenesis in MHV genome 306 fragments was performed using "round the horn" PCR (originally described in (33)). Briefly, 307 adjacent primers containing the mutation of interest were 5¢-phosphorylated using T4 308 polynucleotide kinase (NEB, M0201S) using the buffer from the T4 DNA ligase, which contains 309 ATP (M0202S). PCR was performed on a plasmid template using the Q5 High-fidelity 2x 310
Master Mix (NEB, M0492L), with primers at final concentration of 500nM. The linear 311 amplification product was purified using the Promega Wizard SV Gel and PCR Clean-up System 312 (Promega Corporation, A9282), and 4 µL was ligated at 16°C overnight with the T4 DNA ligase 313 (NEB M0202S). After transformation into chemically-competent Top10 E. coli (lab-derived) and 314 expansion in liquid culture, the MHV segment of each plasmid was sequenced. Viruses were 315 constructed, rescued, and sequenced as described previously (7, 13, 32). Experimental stocks 316
were generated by infecting a subconfluent 150 cm 2 flask of DBT-9 cells at MOI of 0.01 317 PFU/cell. Flasks were frozen at -80°C when monolayers were fully involved, approximately 20-318 28 hours post-infection depending on the variant. After thawing, the supernatant was clarified by 319 centrifugation at 4,000 x g (Sorvall RC 3B Plus; HA-6000A rotor) for 10 min at 4°C. For 320 intermediate revertants, stocks were generated in serum-free DMEM and processed as above 321 before being concentrated roughly 10-fold by centrifugation at 4,000 x g using Amicon Ultra-15 322
Centrifugal Filter Units, 100kDa (EMD Millipore, UFC910008). The virus titer of each stock 323 was determined by plaque assay using DBT-9 cells as described above. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/618249 doi: bioRxiv preprint
